Showing results (91-100 of 198) with videos related to
Sort By:
Pageof 20
Molecular Endocrinology (Baltimore, Md.)|March 23, 2016
Research Resource: Roles for Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) in Systems MetabolismKathrina L Marcelo, Thomas Ribar, Christopher R Means, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 16, 2002
Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069Kendall Wu, Hee-Tae Kim, Jenny L Rodriquez, et al.Lancet (London, England)|August 9, 2003
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancerJenny C Chang, Eric C Wooten, Anna Tsimelzon, et al.Clinical Breast Cancer|January 13, 2004
Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary resultsAndrea E Van Pelt, Syed Mohsin, Richard M Elledge, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotypeDang M Nguyen, Kathy Sam, Anna Tsimelzon, et al.Plos One|August 11, 2012
Selective small molecule Stat3 inhibitor reduces breast cancer tumor-initiating cells and improves recurrence free survival in a human-xenograft modelBhuvanesh Dave, Melissa D Landis, David J Tweardy, et al.Breast Cancer Research and Treatment|May 5, 2011
Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growthAngelo J Casa, Adam S Potter, Simeen Malik, et al.Breast Cancer Research and Treatment|November 2, 2005
Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancersYee-Lu Tham, L Fernando Gomez, Syed Mohsin, et al.Cancer Research|May 20, 2004
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasisSuh-Chin J Lin, Kuo-Fen Lee, Alexander Yu Nikitin, et al.Journal of the National Cancer Institute|January 15, 2009
Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in miceTracy E Strecker, Qiang Shen, Yun Zhang, et al.Pageof 20